XML 77 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Collaboration Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2021
Jun. 30, 2019
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Recognition of revenue     $ 1,754 $ 545  
Deferred revenue     $ 531    
Common Stock          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Number of shares sold     28,750,000    
Ginkgo Collaboration          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Current pre-paid research and development     $ 1,900    
Non-current pre-paid research and development     9,300    
Prepayment to related party for collaboration agreement   $ 30,000      
Related party transaction collaboration agreement, initial term   5 years      
Ginkgo Collaboration | Pre-Funded Warrants          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Warrants to purchase shares of common stock   2,548,117      
Ginkgo Collaboration | Common Stock          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Number of shares sold   6,340,771      
Maximum | Ginkgo Collaboration | Pre-Funded Warrants          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Warrants to purchase shares of common stock   2,548,117      
Roche Collaboration and Option Agreement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Upfront, nonrefundable technology access fee         $ 1,000
Milestones payment upon achievement of certain success criteria         5,000
Upfront payments         $ 1,000
Milestone payments $ 1,000        
Recognition of revenue     1,500    
Roche Collaboration and Option Agreement | Current Liabilities          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Deferred revenue     $ 500    
Roche Collaboration and Option Agreement | Minimum [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaboration in research and development     12 months    
Roche Collaboration and Option Agreement | Maximum          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaboration in research and development     18 months    
Abb Vie Agreement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Recognition of revenue       $ 500